Characteristics and advantages of adeno-associated virus vector-mediated gene therapy for neurodegenerative diseases

被引：36
|
作者：
Qu, Yuan [1 ]
Liu, Yi [2 ]
Noor, Ahmed Fayyaz [3 ]
Tran, Johnathan [4 ]
Li, Rui [1 ]
机构：
[1] Jilin Univ, Dept Hand Surg, Hosp 2, Changchun, Jilin, Peoples R China
[2] Shandong Univ, Dept Orthoped, Qilu Hosp, Jinan, Shandong, Peoples R China
[3] Univ Massachusetts, Dept Chem, Lowell, MA USA
[4] Massachusetts Coll Pharm & Hlth Sci, Dept Premed & Hlth Studies, Boston, MA USA
来源：
NEURAL REGENERATION RESEARCH | 2019年 / 14卷 / 06期
关键词：
nerve regeneration; central nervous system; gene therapy; neurodegenerative disease; viral vector; adeno-associated virus; Alzheimer's disease; Parkinson's disease; Huntington's disease; amyotrophic lateral sclerosis; spinal muscular atrophy; neural regeneration; MUSCULAR-ATROPHY PHENOTYPE; MOUSE MODEL; ALZHEIMERS-DISEASE; CANAVAN-DISEASE; VIRAL VECTORS; DOUBLE-BLIND; AAV VECTORS; SPINAL-CORD; DELIVERY; BRAIN;
D O I：
10.4103/1673-5374.250570
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
Common neurodegenerative diseases of the central nervous system are characterized by progressive damage to the function of neurons, even leading to the permanent loss of function. Gene therapy via gene replacement or gene correction provides the potential for transformative therapies to delay or possibly stop further progression of the neurodegenerative disease in affected patients. Adeno-associated virus has been the vector of choice in recent clinical trials of therapies for neurodegenerative diseases due to its safety and efficiency in mediating gene transfer to the central nervous system. This review aims to discuss and summarize the progress and clinical applications of adeno-associated virus in neurodegenerative disease in central nervous system. Results from some clinical trials and successful cases of central neurodegenerative diseases deserve further study and exploration.
引用
收藏
页码：931 / 938
页数：8
相关论文
共 50 条
  • [41] Adeno-associated virus vector-mediated minidystrophin gene therapy improves dystrophic muscle contractile function in mdx mice
    Watchko, J
    O'Day, T
    Wang, B
    Zhou, LQ
    Tang, Y
    Li, J
    Xiao, X
    HUMAN GENE THERAPY, 2002, 13 (12) : 1451 - 1460
  • [42] Adeno-Associated Virus-Mediated Gene Therapy
    Zaman, Hassan
    Khan, Aakif
    Khan, Khalid
    Toheed, Shazma
    Abdullah, Muhammad
    Zeeshan, Hafiz Muhammad
    Hameed, Abdul
    Umar, Muhammad
    Shahid, Muhammad
    Malik, Kausar
    Afzal, Samia
    CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION, 2023, 33 (06): : 87 - 100
  • [43] Adeno-associated viral vector-mediated gene transduction in mesencephalic slice culture
    Nihira, Tomoko
    Yasuda, Toru
    Hirai, Yukihiko
    Shimada, Takashi
    Mizuno, Yoshikuni
    Mochizuki, Hideki
    JOURNAL OF NEUROSCIENCE METHODS, 2011, 201 (01) : 55 - 60
  • [44] Characterization of Adeno-Associated Viral Vector-Mediated Human Factor VIII Gene Therapy in Hemophilia A Mice
    Greig, Jenny A.
    Wang, Qiang
    Reicherter, Amanda L.
    Chen, Shu-Jen
    Hanlon, Alexandra L.
    Tipper, Christopher H.
    Clark, K. Reed
    Wadsworth, Samuel
    Wang, Lili
    Wilson, James M.
    HUMAN GENE THERAPY, 2017, 28 (05) : 392 - 402
  • [45] Minimum Effective Dose to Achieve Biochemical Correction with Adeno-Associated Virus Vector-Mediated Gene Therapy in Mice with Pompe Disease
    Han, Sang-Oh
    Gheorghiu, Dorothy
    Li, Songtao
    Kang, Hye Ri
    Koeberl, Dwight
    HUMAN GENE THERAPY, 2022, 33 (9-10) : 492 - 498
  • [46] Efficacious Androgen Hormone Administration in Combination with Adeno-Associated Virus Vector-Mediated Gene Therapy in Female Mice with Pompe Disease
    Han, Sang-oh
    Gheorghiu, Dorothy
    Chang, Alex
    Mapatano, Sweet Hope
    Li, Songtao
    Brooks, Elizabeth
    Koeberl, Dwight
    HUMAN GENE THERAPY, 2022, 33 (9-10) : 479 - 491
  • [47] Silencing of T lymphocytes by antigen-driven programmed death in recombinant adeno-associated virus vector-mediated gene therapy
    Velazquez, Victoria M.
    Bowen, David G.
    Walker, Christopher M.
    BLOOD, 2009, 113 (03) : 538 - 545
  • [48] Erratum: Early, sustained efficacy of adeno-associated virus vector-mediated gene therapy in glycogen storage disease type Ia
    D D Koeberl
    B D Sun
    T V Damodaran
    T Brown
    D S Millington
    D K Benjamin
    A Bird
    A Schneider
    S Hillman
    M Jackson
    R M Beaty
    Y T Chen
    Gene Therapy, 2007, 14 : 281 - 281
  • [49] Adeno-associated virus vector as a platform for gene therapy delivery
    Dan Wang
    Phillip W. L. Tai
    Guangping Gao
    Nature Reviews Drug Discovery, 2019, 18 : 358 - 378
  • [50] Erratum: Early, sustained efficacy of adeno-associated virus vector-mediated gene therapy in glycogen storage disease type Ia
    D D Koeberl
    B D Sun
    T V Damodaran
    T Brown
    D S Millington
    D K Benjamin
    A Bird
    A Schneider
    S Hillman
    M Jackson
    R M Beaty
    Y T Chen
    Gene Therapy, 2006, 13 : 1430 - 1430
12345